Drugs Containing Excipient (Inactive Ingredient) SODIUM THIOSULFATE ANHYDROUS

Branded drugs containing SODIUM THIOSULFATE ANHYDROUS excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Anbex Inc	IOSAT	potassium iodide	51803-001	SODIUM THIOSULFATE ANHYDROUS
Anbex Inc	IOSAT	potassium iodide	51803-002	SODIUM THIOSULFATE ANHYDROUS

Generic drugs containing SODIUM THIOSULFATE ANHYDROUS excipient

Company	Ingredient	NDC	Excipient
Anbex Inc	potassium iodide	51803-001	SODIUM THIOSULFATE ANHYDROUS
Anbex Inc	potassium iodide	51803-002	SODIUM THIOSULFATE ANHYDROUS

Market Dynamics and Financial Trajectory for Sodium Thiosulfate Anhydrous

Last updated: February 12, 2026

Market Overview and Key Drivers

Sodium thiosulfate anhydrous (STSA) primarily finds applications in medical, chemical, and photographic sectors. It is used as an antidote for cyanide poisoning, in dechlorination processes, and for silver recovery. The global demand for STSA has experienced consistent growth driven by the expanding medical applications and environmental regulations limiting the use of hazardous chemicals.

Global Market Size and Growth Rate

The global pharmaceutical excipients market, which includes STSA, was valued at approximately $9 billion in 2022, with a compound annual growth rate (CAGR) of 6.2% from 2020 to 2026.[1] While STSA represents a niche segment within this, specific estimates suggest the compounded annual growth for STSA applications ranges between 4% and 6%, fueled primarily by increasing demand for cyanide antidotes and in environmental decontamination.

Market Segments and Regional Insights

• Medical Segment: Synthesis of cyanide antidotes accounts for about 30% of STSA demand. The rise in industrial accidents and emergency medicine protocols supports growth.

• Chemical Industry: Environmental regulations driving dechlorination and silver recovery bolster industrial demand.

• Photographic Industry: Use has declined with digital photography, representing a minor share.

Regional dynamics reflect variations:

• North America: Dominates due to established healthcare systems and stringent environmental policies.
• Asia-Pacific: Fastest growth, driven by industrial expansion and healthcare infrastructure development.
• Europe: Stable, with regulatory pressures influencing manufacturing and usage patterns.

Supply Chain and Production

Major procurers of raw materials include chemical suppliers in China, India, and Europe. Large-scale manufacturers operate integrated facilities producing STSA with capacities ranging from 1,000 to 5,000 metric tons annually. Production costs are influenced by raw material prices, energy costs, and regulatory compliance expenses.

Regulatory Environment Impact

U.S. Food and Drug Administration (FDA) approval protocols and European Medicines Agency (EMA) regulations impact manufacturing and application scope. Changing regulations on hazardous chemicals influence supply chain adaptations and R&D investment.

Financial Trajectory and Investment Outlook

While specific financials for STSA are limited—given its niche position—related data suggest:

• Steady growth in R&D investments by pharmaceutical companies exploring new antidote formulations.
• Potential for price stability due to limited substitutes, but vulnerability to raw material price fluctuations.
• Entry barriers for new producers owing to regulatory complexity and manufacturing costs.

Market players focus on process improvements to reduce costs, and biotechnological innovations to expand applications.

Pricing Trends

Average prices for STSA have remained stable over the last five years, roughly between $2,000 and $3,000 per metric ton in bulk sales, influenced by production costs and demand stability. Price hikes correlate with raw material scarcity or regulatory changes.

Forecast and Opportunities

Projections point to consistent demand growth in healthcare and environmental sectors, with potential expansion into novel therapeutic applications. R&D efforts targeting improved formulations and manufacturing efficiencies could result in higher margins.

Key Takeaways

• Global demand for STSA remains stable, with growth driven mainly by medical and environmental sectors.
• Manufacturing tends to concentrate in Asia-Pacific, with key players in China and India.
• Regulatory landscapes significantly influence supply chain and product development.
• Pricing remains stable, with modest growth expectations; raw material costs pose risks.
• Innovation in antidote applications and manufacturing efficiency presents opportunities for market expansion.

FAQs

1. What are the main applications of sodium thiosulfate anhydrous?
Primarily used as an antidote for cyanide poisoning, in dechlorination, and silver recovery in industrial processes.

2. Which regions lead in the production and consumption of STSA?
North America and Asia-Pacific are the largest markets, with China and India leading in manufacturing.

3. How do regulatory policies impact the pharmaceutical excipient market?
Regulations influence manufacturing standards, approval processes, and application scope, potentially increasing costs and affecting supply chains.

4. What are the key factors influencing the price of STSA?
Raw material availability, regulatory compliance costs, and demand stability are primary drivers.

5. What future trends could influence the market for STSA?
Innovations in antidote formulations, environmental regulations, and manufacturing process improvements are expected to shape future demand and supply.

---

References

[1] Grand View Research. "Pharmaceutical Excipients Market Size, Share & Trends Analysis Report," 2022.